cdmo.directory
← Compare landing

Dipharma vs PHT International, Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/dipharma/phtinternational

CategoryDipharmaPHT International, Inc.
Listed sitecdmocdmo
SummaryGlobal CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.PHT International is a Contract Research, Development, and Manufacturing Organization (CRDMO) offering small-molecule process R&D, cGMP manufacturing from milligrams to multi-tons, and chemical sourcing with global facilities across North America, Europe, and Asia.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Process Development
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Technology Transfer
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Small Molecule
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
  • Headquarters, Charlotte, NC, USA
  • Shanghai Office, Shanghai, China
  • Beijing Office, Beijing, China
  • Ningbo, Ningbo, Zhejiang, China
  • Hong Kong, Hong Kong, Hong Kong
  • Nantong, Nantong, Jiangsu, China
  • Shangyu, Shangyu, Zhejiang, China
  • Barr, Barr, Switzerland
  • Tokyo, Tokyo, Japan
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.